Bandingkan Harga & Kinerja Mark Dynamics Indonesia Tbk. (MARK) vs Tempo Scan Pacific Tbk. (TSPC)
Kinerja harga (24 Jam Terakhir)
Statistik utama
Statistik utama
Perbedaan Mark Dynamics Indonesia Tbk. dan Tempo Scan Pacific Tbk.: Mark Dynamics Indonesia Tbk. diperdagangkan di Rp1.125 (kapitalisasi pasar 4,18 T, volume 24 jam 26,75 jt), sedangkan Tempo Scan Pacific Tbk. diperdagangkan di Rp2.590 (kapitalisasi pasar 11,36 T, volume 24 jam 1,77 jt). Perbedaan utamanya: Tempo Scan Pacific Tbk. jauh lebih besar — sekitar 2,7× kapitalisasi pasar Mark Dynamics Indonesia Tbk., dan Mark Dynamics Indonesia Tbk. lebih aktif diperdagangkan (26,75 jt vs 1,77 jt). Mana yang lebih baik tergantung tujuan investasimu.
| MARK | TSPC | |
|---|---|---|
Kapitalisasi Pasar | 4,18 T | 11,36 T |
Volume | 26,75 jt | 1,77 jt |
Lot | 267,48 rb | 17,71 rb |
Perputaran | 29,98 M | 4,61 M |
Harga Rata-rata | 1.120,77 | 2.603,9 |
Nilai Transaksi | 29,98 M | 4,61 M |
Harga Ekuilibrium Indikatif | 1.125 | 2.590 |
Volume Ekuilibrium Indikatif | 246 | 300 |
Perbandingan imbal hasil
Imbal hasil berjalan pada periode standar
Perbandingan imbal hasil
Imbal hasil berjalan pada periode standar
Berita terkini
Berita terbaru kedua aset
Berita terkini
Berita terbaru kedua aset
Tentang Mark Dynamics Indonesia Tbk.
PT Mark Dynamics Indonesia Tbk (the Company) was established based on the Deed No. 03 dated April 10, 2002 drawn up before Fibriani Magdalena Hasibuan, SH Notary in Medan. The Company started its commercial operations in September 2003. In 2013 the company decided to invest by purchasing 100% of Honor Tower SDN BHD.
Selengkapnya di halaman MARK →Tentang Tempo Scan Pacific Tbk.
PT. Tempo Scan Pacific Tbk (the Company) was established in the Republic of Indonesia dated 20 May 1970, under its original name PT Scanchemie within the framework of the Domestic Capital Investment Law No. 6 year 1968, as amended by Law No. 12 year 1970, based on Notarial Deed No. 37 of Ridwan Suselo, S.H. The company is famous for such pharmaceutical products as Bodrex, Hemaviton and Neo-Rheumacyl.
Selengkapnya di halaman TSPC →
